In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of wellness. Jeff Stevens, CEO of Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9), and Harrison Aaron of cannabis investment firm Gotham Green were about to embark on a journey fueled by the potential of the Amanita Muscaria mushroom.
What's Psyched Wellness
Psyched Wellness is a pioneer in the field of life sciences. Its focus is the production and distribution of wellness products derived from the Amanita Muscaria mushroom.
The company has developed its proprietary extract, AME-1, which, after years of thorough studies and stringent US GRAS certification, has proven safe for human consumption.
A Multi-Million Dollar Conversation
The meeting between Stevens and Aaron led to a binding agreement between Psyched Wellness and Gotham Green Fund III. This collaboration paves …